Transradial approach (TRA) has been more and more accepted for cardiovascular operations. TRA uncommonly leads to hemorrhagic and vascular complications. CHA2DS2-VASc score is utilized to estimation the risk of thrombosis in patients with atrial fibrillation. We intended to assess the relationship between the CHA2DS2- VASc score or components of this score and radial artery complications after transradial coronary angiography. A total of 412 consecutive patients who underwent a TRA were evaluated in this study. Patients were divided into two groups as total complications (n= 73) and no-complications (n= 339) groups. The CHA2DS2-VASc score was higher in patients who had total complications group yet it was not statistically significant (p=.149). Total complication group were older compared to control group (p=.017). As the radial artery diameter decreased, and sheath/radial artery diameter increased, the risk of the total complication group higher significantly (for all; p
___
1. Feldman DN, RV Swaminathan, LA Kaltenbach, et al. Adoption of radial access and comparison of outcomes to femoral access in percutaneous coronary intervention: an updated report from the national cardiovascular data registry (2007-2012). Circulation. 2013;127:2295-306.
2. Cooper CJ, RA El-Shiekh, DJ Cohen, et al. Effect of transradial access on quality of life and cost of cardiac catheterization: A randomized comparison. Am Heart J. 1999;138:430-6.
3. Spaulding C, T Lefevre, F Funck, et al. Left radial approach for coronary angiography: results of a prospective study. Cathet Cardiovasc Diagn.1996; 39:365-70.
4. Tatli E, A Buturak, A Cakar, et al. Unusual vascular complications associated with transradial coronary procedures among 10,324 patients: case based experience and treatment options. J Interv Cardiol. 2015;28:305-12.
5. Hirsh J, R Raschke. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:188-203.
6. Saliba W, N Gronich, O Barnett-Griness, et al. Usefulness of CHADS2 and CHA2DS2-VASc Scores in the prediction of new-onset atrial fibrillation: a population-based study. Am J Med. 2016;129:843-9.
7. Lip GYR. Nieuwlaat, R Pisters, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137:263-72.
8. Melgaard LA, Gorst-Rasmussen. DA Lane et al. Assessment of the CHA2DS2-VASc score in predicting ischemic stroke, thromboembolism, and death in patients with heart failure with and without atrial fibrillation. Jama. 2015;314:1030-8.
9. Biancari F, MA Asim Mahar, OP Kangasniemi. CHADS2 and CHA2DS2- VASc scores for prediction of immediate and late stroke after coronary artery bypass graft surgery. J Stroke Cerebrovasc Dis. 2013;22:1304-11.
10. Mitchell LB, DA Southern, D Galbraith, et al. Prediction of stroke or TIA in patients without atrial fibrillation using CHADS2 and CHA2DS2-VASc scores. Heart. 2014;100:1524-30.
11. Balci KG, O Maden, MM Balci, et al. Relation Between TRCA complication rates and peak ACT levels stratified according to the BMI tertiles. Angiology. 2018;69:400-5.
12. Burzotta FC, Trani MA, Mazzari et al. Vascular complications and access crossover in 10,676 transradial percutaneous coronary procedures. Am Heart J. 2012;163:230-8.
13. Agostoni P, GG Biondi-Zoccai, ML de Benedictis, et al. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trials. J Am Coll Cardiol. 2004;44:349-56.
14. Louvard Y, T Lefevre, A Allain, et al. Coronary angiography through the radial or the femoral approach: The CARAFE study. Catheter Cardiovasc Interv. 2001;52:181-7.
15. Mattea V, C Salomon, N Menck, et al. Low rate of access site complications after transradial coronary catheterization: A prospective ultrasound study. Int J Cardiol Heart Vasc. 2017;14:46-52.
16. Camm AJ, GY Lip, R De Caterina, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. Europace. 2012;14:1385-413.
17. Trantalis G, K Aggeli, K Toutouzas, et al. The prognostic value of CHA2DS2-VASc and GRACE risk scores in patients with ACS. Hellenic J Cardiol, 2018.
18. Mirbolouk F, M Gholipour, A Salari, et al. CHA2DS2-VASc score predict no-reflow phenomenon in primary percutaneous coronary intervention in primary percutaneous coronary intervention. J Cardiovasc Thorac Res. 2018;10:46-52.
19. Kurtul A. Usefulness of the CHA2DS2-VASc score in predicting in-stent restenosis among patients undergoing revascularization with bare-metal stents. Clin Appl Thromb Hemost. 2018;24:589-95.
20. Unal S, B Acar, C Yayla, et al. Importance and usage of the CHA2DS2- VASc score in predicting acute stent thrombosis. Coron Artery Dis. 2016; 27:478-82.
21. Ipek G, T Onuk, MB Karatas, et al. CHA2DS2-VASc score is a predictor of no-reflow in patients with st-segment elevation myocardial infarction who underwent primary percutaneous intervention. Angiology. 2016;67:840-5.
22. Chan YH, KH Yiu, KK Lau, et al. The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation. Atherosclerosis. 2014;237:504-13.
23. Iwakura K, H Ito, M Ikushima, et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol. 2003;41:1-7.
24. Di Carli MF, J Janisse, G Grunberger, et al. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol. 2003;41:1387-93.
25. Dean J, SD Cruz, PK Mehta, et al. Coronary microvascular dysfunction: sex-specific risk, diagnosis, and therapy. Nat Rev Cardiol. 2015;12:406-14.
26. Crea F, PG Camici, CN Bairey Merz. Coronary microvascular dysfunction: an update. Eur Heart J. 2014;35:1101-11.
27. Badr S, H Kitabata, R Torguson, et al. Incidence and correlates in the development of iatrogenic femoral pseudoaneurysm after percutaneous coronary interventions. J Interv Cardiol. 2014;27:212-6.
28. Sanmartin M, D Cuevas, J Goicolea, et al. Vascular complications associated with radial artery access for cardiac catheterization. Rev Esp Cardiol. 2004;57:581-4.
29. Ge J. R Erbel, HJ Rupprecht, et al. Comparison of intravascular ultrasound and angiography in the assessment of myocardial bridging. Circulation. 1994;89:1725-32.
30. Ge J, R Erbel, G Gorge, et al. High wall shear stress proximal to myocardial bridging and atherosclerosis: intracoronary ultrasound and pressure measurements. Br Heart J. 1995;73:462-5.
31. Wilk G, G Osmenda, P Matusik, et al. Endothelial function assessment in atherosclerosis: comparison of brachial artery flow‑mediated vasodilation and peripheral arterial tonometry. Polish Arc Int Med. 2013;123:443-52.
32. Duca L, S Blaise, B Romier, et al. Matrix ageing and vascular impacts: focus on elastin fragmentation. Cardiovas res. 2016;110:298-308.
33. Lakatta EG. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging. Circulation. 2003;107:490-7.